The Journal of Clinical Endocrinology & Metabolism · 2009 · 20 citations · 35 references
MedicineEndocrinologyGeneticsEndocrine GeneticsMedical GeneticsPediatric EndocrinologyChild GrowthGrowth DisordersInsulin ResistanceIntrauterine Growth RestrictionMetabolic SyndromeGrowth-related BiomarkersInsulin-like Growth Factor GeneticsInsulin-like Growth Factor-1Insulin-like Growth FactorsPediatric Metabolic SyndromeShort Stature GeneticsStature Variation
CONTEXT: IGF binding protein (IGFBP)-1 is the only acute regulator of IGF-I bioavailability. Its production is suppressed by insulin, and low levels are associated with hyperinsulinemia and cardiovascular disease risk in adults. Data on IGFBP-1 levels in short, small for gestational age (SGA) subjects are scarce, and associations with IGFBP1 promoter single nucleotide polymorphisms have not been established. OBJECTIVE: The aim of the study was to determine IGFBP-1 levels in short SGA subjects compared with those in controls, to assess genotype frequency of the -575 G/A single nucleotide polymorphism, and to determine its impact on IGFBP-1 levels. SUBJECTS: A total of 272 short subjects born SGA and 330 subjects with normal stature (245 children, 85 young adults) participated in the study. OUTCOME MEASURES: We measured fasting levels of IGFBP-1, IGF-I, insulin and lipid parameters, and body composition. RESULTS: IGFBP-1 sd score (SDS) was comparable to controls in lean, short, SGA children but significantly lower in short SGA adults with normal fat mass (P < 0.001). IGFBP-1 SDS correlated significantly with insulin levels, systolic blood pressure SDS, and various lipid parameters. Baseline IGFBP-1 SDS was lowest in SGA children with -575 GG genotype and significantly higher in SGA children with one or two copies of the A allele. In response to a given insulin level, children with the AA genotype had a significantly higher IGFBP-1 SDS compared to children with the GG genotype. CONCLUSION: Normal IGFBP-1 levels in lean, short, SGA children may reflect a normal metabolic state, despite reported hyperinsulinemia. IGFBP-1 is modulated by polymorphic variability and seems to be an additional player in the complex interaction between the IGF-IGFBP axis, glucose homeostasis, and lipid metabolism.
35
Trajectories of Growth among Children Who Have Coronary Events as Adults
David J.P. Barker, Clive Osmond, Tom Forsén et al. · New England Journal of Medicine · 2005 · 1.5K citations · Full text
Recommended dietary intakes in Denmark.
Jens H. Jensen · PubMed · 1990 · 1.3K citations
Continuing Positive Secular Growth Change in the Netherlands 1955–1997
A.M. Fredriks, Stef van Buuren, Ruud J F Burgmeijer et al. · Pediatric Research · 2000 · 1.1K citations
Early growth and coronary heart disease in later life: longitudinal study
Johan G. Eriksson · BMJ · 2001 · 1K citations · Full text